These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 3005169)

  • 21. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats.
    Dukacz SA; Adams MA; Kline RL
    Am J Physiol; 1997 Jul; 273(1 Pt 2):F104-12. PubMed ID: 9249597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired renal haemodynamic response to amino acid infusion in essential hypertension during angiotensin converting enzyme inhibitor treatment.
    Tietze IN; Sørensen SS; Ivarsen PR; Nielsen CB; Pedersen EB
    J Hypertens; 1997 May; 15(5):551-60. PubMed ID: 9170009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enalapril and pressure-diuresis in hypertensive rats transgenic for mouse renin gene.
    Springate J; Van Liew J; Ganten D
    Kidney Blood Press Res; 1997; 20(1):1-5. PubMed ID: 9192903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin suppression by saline is blunted in nonmodulating essential hypertension.
    Rabinowe SL; Redgrave JE; Shoback DM; Podolsky S; Hollenberg NK; Williams GH
    Hypertension; 1987 Oct; 10(4):404-8. PubMed ID: 3308701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged converting enzyme inhibition in non-modulating hypertension.
    Dluhy RG; Smith K; Taylor T; Hollenberg NK; Williams GH
    Hypertension; 1989 Apr; 13(4):371-7. PubMed ID: 2538393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?
    van Paassen P; de Zeeuw D; Navis G; de Jong PE
    Hypertension; 1996 Feb; 27(2):202-8. PubMed ID: 8567042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal effects of angiotensin converting enzyme inhibitors in hypertension.
    Bauer JH; Reams GP
    Am J Med; 1986 Oct; 81(4C):19-27. PubMed ID: 3022581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertension.
    van Paassen P; Navis GJ; De Jong PE; De Zeeuw D
    Eur J Clin Invest; 1999 Dec; 29(12):1019-26. PubMed ID: 10583449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP; Bauer JH; Gaddy P
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral and renal effects of MK-421 (enalapril) in hypertensive subjects.
    de Leeuw PW; Hoogma RP; van Soest GA; Tchang PT; Birkenhäger WH
    J Cardiovasc Pharmacol; 1983; 5(5):731-6. PubMed ID: 6195458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The renin-aldosterone system in exaggerated natriuresis of essential hypertension.
    Pedersen EB; Kornerup HJ
    Clin Sci Mol Med; 1977 Dec; 53(6):573-8. PubMed ID: 589941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium metabolism in essential hypertension. Natriuretic response to acute hypertonic saline load.
    Kubo S; Nishioka A; Takatsu T
    Jpn Heart J; 1978 Nov; 19(6):852-64. PubMed ID: 750669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB; Johnson A; Gabow PA; Schrier RW
    N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal sodium handling abnormalities in hypertensive and normotensive patients with a family history of hypertension.
    Ramirez AJ; Gimenez MI; Gallo J; Marco EJ; Sanchez RA
    J Hypertens Suppl; 1989 Dec; 7(6):S178-9. PubMed ID: 2561138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of angiotensin-converting enzyme inhibition on renal dysfunction induced by moderate potassium depletion in healthy women.
    Agnoli GC; Borgatti R; Cacciari M; Ikonomu E; Lenzi P; Marinelli M
    Clin Physiol; 1994 Mar; 14(2):205-22. PubMed ID: 8205752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of deranged sodium homeostasis in essential hypertension.
    Epstein M; Loutzenhiser R; Levinson R
    Hypertension; 1986 May; 8(5):422-32. PubMed ID: 3516871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.